DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test By Investing.com
AdminDermTech (DMTK) Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test DermTech, Inc. (NASDAQ:) (“DermTech” or the “Company”), a leader in precision dermatology…